Improved efficacy of doxorubicin delivery by a novel dual-ligand-modified liposome in hepatocellular carcinoma-Reference-Cited by-同舟云学术

Improved efficacy of doxorubicin delivery by a novel dual-ligand-modified liposome in hepatocellular carcinoma

Published:2020-10 Issue: Volume:489 Page:163-173
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Li Xiaocheng^ORCID,Diao Wenbin,Xue Hantao,Wu Fei,Wang Weiyu,Jiang Bin,Bai Jingkun^ORCID,Lian Bo,Feng Weiguo,Sun Tongyi,Yu Wenjing^ORCID,Wu Jingliang,Qu Meihua,Wang Yubing,Gao Zhiqin

Funder

National Natural Science Foundation of China, China

Natural Science Foundation of Shandong Province, China

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference41 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;Ca - Cancer J. Clin.,2018

2. Epidemiology of viral hepatitis and hepatocellular carcinoma;El-Serag;Gastroenterology,2012

3. Gene therapy for liver cancers: current status from basic to clinics;Kamimura;Cancers,2019

4. A global view of hepatocellular carcinoma: trends, risk, prevention and management;Yang;Nat. Rev. Gastroenterol. Hepatol.,2019

5. Angiogenesis inhibitors for the treatment of hepatocellular carcinoma;Berretta;Front. Pharmacol.,2016

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Natural compounds-based nanomedicines for cancer treatment: Future directions and challenges;Drug Delivery and Translational Research;2024-07-13

2. Multifunctional and stimuli-responsive liposomes in hepatocellular carcinoma diagnosis and therapy;Translational Oncology;2024-07

3. Improved efficacy of cisplatin delivery by peanut agglutinin‑modified liposomes in non‑small cell lung cancer;International Journal of Molecular Medicine;2024-07-01

4. Nano-based drug delivery systems in hepatocellular carcinoma;Journal of Drug Targeting;2024-06-18

5. Paeoniflorin loaded liposomes modified with glycyrrhetinic acid for liver-targeting: preparation, characterization, and pharmacokinetic study;Pharmaceutical Development and Technology;2024-02-29